Qlife Holding announces the outcome of the exercise of warrants series TO 2
The board of directors of Qlife Holding AB (“Qlife” or the “Company”) today announces the outcome of the exercise period for warrants series TO 2, which were issued in connection with the Company’s rights issue of units in October 2022 (the “Rights Issue”). The subscription rate was approximately 0.17 per cent and Qlife thereby receives approximately SEK 3 thousand before issue costs.
In total, Qlife issued 2,884,980 units in the Rights Issue, each consisting of one (1) share and one (1) warrant series TO 2. One (1) warrant entitled the right to subscribe for 1.08 new shares in the Company at an exercise price of SEK 0.21 per share. The exercise period of the warrants ran from 7 – 21 June 2023. The outcome shows that 12,987 warrants were utilized for subscription of 14,023 shares, meaning a subscription rate of approximately 0.17 per cent. Exercised warrants have been replaced with interim shares pending registration with the Swedish Companies Registration Office. The interim shares are expected to be converted into shares during week 27, 2023.
Through the exercise of the warrants the Company receives approximately SEK 3 thousand before issue costs. The total number of shares in Qlife increases by 14,023, from 645,421,476 to 645,435,499. The share capital in Qlife increases by SEK 1,121.84, from SEK 51,633,718.08 to SEK 51,634,839.92.